Award recordCONTRACT

THE BLOOD CENTER

PIID 36C25618D0008· VHA· 256-NETWORK CONTRACT OFFICE 16 (36C256)· 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS· FY2018· $0 net obligations· UEI SCFJBJWLMXT6· LA

Description

BLOOD&BLOOD RELATED PRODUCTS - EXERCISE OPTION YEAR 3

Base award description: BLOOD&BLOOD RELATED PRODUCTS

First action · last action
2017-11-01 · 2022-10-01
Transactions
6
First transaction's obligation
$0
Base + all options value (sum of deltas)
$896,470
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
621991 · BLOOD AND ORGAN BANKS

Modification chain · 6 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1$0Base award · 2017-11-01 · this action $0 · running total $0Modification P00001 · 2018-08-31 · this action $0 · running total $0Modification P00002 · 2019-08-26 · this action $0 · running total $0Modification P00003 · 2020-08-28 · this action $0 · running total $0Modification P00004 · 2021-10-01 · this action $0 · running total $0Modification P00005 · 2022-10-01 · this action $0 · running total $0
  • Base2017-11-01+$0= $0
  • Mod P000012018-08-31+$0= $0
  • Mod P000022019-08-26+$0= $0
  • Mod P000032020-08-28+$0= $0
  • Mod P000042021-10-01+$0= $0
  • Mod P000052022-10-01+$0= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2017-11-01+$0$0BLOOD&BLOOD RELATED PRODUCTS
Mod P00001· EXERCISE AN OPTION2018-08-31+$0$0BLOOD&BLOOD RELATED PRODUCTS - EXERCISE OPTION YEAR 1
Mod P00002· EXERCISE AN OPTION2019-08-26+$0$0BLOOD&BLOOD RELATED PRODUCTS - EXERCISE OPTION YEAR 2
Mod P00003· EXERCISE AN OPTION2020-08-28+$0$0BLOOD&BLOOD RELATED PRODUCTS - EXERCISE OPTION YEAR 3
Mod P00004· EXERCISE AN OPTION2021-10-01+$0$0BLOOD&BLOOD RELATED PRODUCTS - EXERCISE OPTION YEAR 3
Mod P00005· EXERCISE AN OPTION2022-10-01+$0$0BLOOD&BLOOD RELATED PRODUCTS - EXERCISE OPTION YEAR 3

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI SCFJBJWLMXT6)

AwardOffice · PSC / listingNet obligationsFY
36C25626D0050256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$0FY2026
36C25626N0450256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$324,605FY2026
36C25626N0432256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$245,189FY2026
36C25626N0069256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$135,008FY2026
36C25625N0652256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$162,292FY2025
36C25625N0007256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$307,339FY2025

Other recipients under 6550 from 256-NETWORK CONTRACT OFFICE 16 (36C256) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25626P0524ROCHE DIAGNOSTICS CORPORATION256-NETWORK CONTRACT OFFICE 16 (36C256)$134,375FY2026
36C25626N0413TOSOH BIOSCIENCE, INC.256-NETWORK CONTRACT OFFICE 16 (36C256)$32,760FY2026
36C25626N0406CEPHEID256-NETWORK CONTRACT OFFICE 16 (36C256)$800,000FY2026
36C25626D0035CEPHEID256-NETWORK CONTRACT OFFICE 16 (36C256)$0FY2026
36C25626P0326CEPHEID256-NETWORK CONTRACT OFFICE 16 (36C256)$379,242FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36C25618D0008_3600 · retrieved 2026-09-26.